More Serious Adverse Events Seen With Debulking + Systemic Therapy in Metastatic CRC

FRIDAY, Oct. 20, 2023 -- For patients with multiorgan metastatic colorectal cancer (mCRC), adding maximum tumor debulking to systemic therapy is associated with more serious adverse events but no difference in health-related quality of life (HRQoL),...